ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study
暂无分享,去创建一个
L. Dauchet | A. Meirhaeghe | K. Faure | D. Mathieu | P. Amouyel | J. Poissy | V. Gauthier | P. Goldstein | M. Lambert | C. Yelnik | A. Facon | S. Panaget | T. Plagnieux | F. Verfaillie